News
Barchart on MSN4d
Regeneron Pharmaceuticals Earnings Preview: What to ExpectRegeneron Pharmaceuticals will release its second-quarter earnings next month, and analysts anticipate a double-digit profit ...
Zacks Investment Research on MSN4d
Regeneron (REGN) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 ReleaseThe market expects Regeneron (REGN) to deliver a year-over-year decline in earnings on lower revenues when it reports results ...
Zacks Investment Research on MSN7h
Unlocking Q2 Potential of Regeneron (REGN): Exploring Wall Street Estimates for Key MetricsWall Street analysts forecast that Regeneron (REGN) will report quarterly earnings of $8.03 per share in its upcoming release, pointing to a year-over-year decline of 30.5%. It is anticipated that ...
S&P 500 EPS growth is expected to come in at 4.8% for Q2, which would be the lowest growth rate since Q4 2023.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback